{
  "id": 20640072,
  "title": "‘Selling and marketing snake oil’: The debate over compounded GLP-1s",
  "url": "https://urgent.news/2026/11/18/selling-and-marketing-snake-oil-the-debate-over-compounded-glp-1s",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T18:51:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/compounded-glp-1s-telehealth-debate-snake-oil-fda/875065/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Proponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Healthcare Dive",
        "title": "‘Selling and marketing snake oil’: The debate over compounded GLP-1s",
        "url": "https://urgent.news/2026/11/17/selling-and-marketing-snake-oil-the-debate-over-compounded-glp-1s",
        "published": "2026-11-17T15:51:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}